Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ
about
Insidious changes in stromal matrix fuel cancer progressionThe microenvironment in breast cancer progression: biology and implications for treatmentNext-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situMesenchymal stem cell secretome and regenerative therapy after cancerThe wound healing, chronic fibrosis, and cancer progression triadUnderstanding the impact of 2D and 3D fibroblast cultures on in vitro breast cancer modelsThe clinical and functional significance of c-Met in breast cancer: a reviewTGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling MechanismsPathomimetic avatars reveal divergent roles of microenvironment in invasive transition of ductal carcinoma in situA RAB5/RAB4 recycling circuitry induces a proteolytic invasive program and promotes tumor dissemination.Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migrationMalignant precursor cells pre-exist in human breast DCIS and require autophagy for survivalMesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms.Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.Myofibroblastic stromal reaction and lymph node status in invasive breast carcinoma: possible role of the TGF-β1/TGF-βR1 pathway.Fibroblast heterogeneity in the cancer wound.Functional screen of paracrine signals in breast carcinoma fibroblasts.Longitudinal study of mammary epithelial and fibroblast co-cultures using optical coherence tomography reveals morphological hallmarks of pre-malignancy.RNA-Seq of human breast ductal carcinoma in situ models reveals aldehyde dehydrogenase isoform 5A1 as a novel potential target.Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer.Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway.Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.Breast cancer subtype-specific interactions with the microenvironment dictate mechanisms of invasion.Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironmentStearoyl-CoA desaturase 1 and paracrine diffusible signals have a major role in the promotion of breast cancer cell migration induced by cancer-associated fibroblastsHepatic stellate cells: central modulators of hepatic carcinogenesis.Tumor budding in colorectal carcinoma assessed by cytokeratin immunostaining and budding areas: possible involvement of c-Met.Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation.A microengineered pathophysiological model of early-stage breast cancer.Fibroblasts--a key host cell type in tumor initiation, progression, and metastasis.MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression.An "elite hacker": breast tumors exploit the normal microenvironment program to instruct their progression and biological diversity.Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancerPathomimetic cancer avatars for live-cell imaging of protease activity.The crosstalk: Tumor-infiltrating lymphocytes rich in regulatory T cells suppressed cancer-associated fibroblasts.3D/4D functional imaging of tumor-associated proteolysis: impact of microenvironment.Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment.Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix.Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity.Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.
P2860
Q26851261-0D34C2E9-3AD4-4EC2-8B3B-30AFDFA14359Q26851314-8E455D5B-53C9-436B-BE6D-BED4E5EDD56DQ26864448-4CE93886-491E-4BA9-BEF7-3046B523089CQ27007499-9F068FDE-1301-40C3-A699-52576849BCBCQ27014616-4D579ED2-FA10-48D9-BA86-CE5DB5965AD1Q27304708-BC4C7312-19B0-4090-90C8-B1403F6B0ED4Q28081415-044474BE-D69C-4890-A2D9-B3836FEE3575Q28547113-87FB9E32-8D99-407B-A723-47BE8BD0B73DQ29994686-8D8778E6-26D7-4024-8209-D0F3DDC8EF5EQ30584664-44BFCB04-C88A-40D4-91F8-BB8D6CD483D8Q30660919-15F713AE-410D-48F5-A5DB-CA5B8A1DA0CAQ33565313-5F1D1BF8-5146-4CDD-9751-3B7CCDDED669Q33753147-66A0CC96-770A-4E11-940E-D0B3CC95DD6FQ33880064-9771AFA4-102F-4A48-9D2F-08F6312A574BQ33904807-DADF731A-64A7-45C9-8B3D-2EBEDAFF7AE3Q33964324-A5490D1A-FCC3-4B3D-9777-A7E1051452C7Q34441858-C033A6FD-EFDB-4304-A510-8794B2F31D8CQ34477782-425DDBCB-DBF3-4767-9B1F-AE9218639C49Q34510318-6421ABE2-0F9D-46F6-85E5-907A3CAC5730Q34552074-F41FC11E-6A83-4972-A94D-63B9320988ECQ35099927-ECC0689D-E4C9-499B-984B-81CBFC32097FQ35439417-15574F3B-4A50-48FF-A437-CA3869FC2CBEQ35501726-7273A881-6B61-4AA6-A95D-514C836A0DD0Q35597185-65EA8E5E-7604-4D15-8531-BB8B1F67DAC0Q35603668-0B3B72F7-E8C3-4EC8-A39D-BFBDB56E6E04Q35642468-015B1F15-F81A-49DB-8D82-51D5BADDFE6EQ35713396-5A20132F-9646-40A9-B221-A62320313686Q35883071-776F0F7A-ED5B-4344-AC66-23913EACD255Q35916132-A2CA8D91-A8AB-4F80-BA3C-2C35418FC19FQ35920503-5285F8BB-B420-489C-B4BB-4130DBDA1E25Q36038319-887591FF-70C7-481E-82BA-4E13E2335B0EQ36187733-A5D1E38E-B9F8-415B-8784-9B92D7BCDE1CQ36578574-B0A98509-3C53-41BE-BD10-B8B47817DBC7Q37166691-975C3B04-D39E-4B1B-866F-595A5E0E00C8Q37267037-1BD0C930-B9B5-499E-B2FE-91859D741ED2Q37353288-6F07E1E7-A877-46BA-A087-26E3FEFDF6C2Q37580230-7B1358D2-D573-4F77-B8AF-FCEF35065432Q37610995-4652D267-3E93-436D-913A-3BD9EDF950E8Q37651981-B02F601D-E425-4035-9AB8-7B4306C972B5Q37690034-9B1B70AD-1370-425A-9967-BD5A2B3236C0
P2860
Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Fibroblast hepatocyte growth f ...... mmary ductal carcinoma in situ
@en
Fibroblast hepatocyte growth f ...... mary ductal carcinoma in situ.
@nl
type
label
Fibroblast hepatocyte growth f ...... mmary ductal carcinoma in situ
@en
Fibroblast hepatocyte growth f ...... mary ductal carcinoma in situ.
@nl
prefLabel
Fibroblast hepatocyte growth f ...... mmary ductal carcinoma in situ
@en
Fibroblast hepatocyte growth f ...... mary ductal carcinoma in situ.
@nl
P2093
P2860
P1433
P1476
Fibroblast hepatocyte growth f ...... mmary ductal carcinoma in situ
@en
P2093
Bernadette C Victor
Bonnie F Sloane
Christopher Jedeszko
Izabela Podgorski
P2860
P304
P356
10.1158/0008-5472.CAN-09-1043
P407
P577
2009-11-17T00:00:00Z